Exhibit 23.2
|
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 of Protalix BioTherapeutics, Inc. of our report dated February 27, 2023 relating to the financial statements, which appears in Protalix BioTherapeutics, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2022.
| Tel-Aviv, Israel | /s/ Kesselman & Kesselman |
| August 11, 2023 | Certified Public Accountants (lsr.) |
| A member firm of PricewaterhouseCoopers | |
| International Limited |
Kesselman & Kesselman, Derech Menachem Begin 146, Tel-Aviv 6492103, Israel,
P.O Box 7187 Tel-Aviv 6107120, Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.com/il
Kesselman & Kesselman is a member firm of PricewaterhouseCoopers International Limited, each member firm of which is a separate legal entity